Drimva

AstraZeneca

Study Physician, Immunology

$204K–$306K

US - Cambridge Kendall SQ - MA · Full-time · Posted Oct 29, 2026

Experience
8 years’ experience, an MD or equivalent degree, or an MD (or equivalent) plus a PhD; prior biotechnology or pharmaceutical clinical-development experience is required.
Education
MD or equivalent degree from an accredited university, or an MD (or equivalent) plus a PhD; postgraduate subspecialty training and board certification in a relevant field.

About the job

Provides study-level medical and scientific leadership for clinical development programs in rheumatology and other immune-mediated diseases, from study design through delivery, interpretation, and safety oversight.

What you'll do

  • Design, oversee, interpret, and monitor clinical studies from Phase 1 through pivotal, ensuring GCP compliance and data quality.
  • Lead medical safety assessments and represent studies at safety committees and governance forums.
  • Advise cross-functional teams and contribute medical content and review to study- and program-level documents.

What they ask for

  • 8 years’ experience, an MD or equivalent degree, or an MD (or equivalent) plus a PhD, with immunology or neuroimmunology specialty or experience.
  • Postgraduate subspecialty training and board certification in a relevant field, with substantive attending- or consultant-level clinical experience.
  • Biotechnology or pharmaceutical clinical-development experience, including hands-on industry-sponsored study design, delivery, interpretation, and oversight.
  • Knowledge of FDA, EMA, MHRA, and ICH GCP guidelines for global clinical studies.

Nice to have

  • Experience in CAR-T or other engineered cell therapies, and/or T-cell engagers, in autoimmune or inflammatory indications.
  • Experience in Sjogren’s Disease or myositis.

Pay

$203,709.60 - $305,564.40 USD base pay

Tools

FDA, EMA, MHRA, ICH GCP, CAR-T, T-cell engagers, CMC

Model-written summary · the original posting is authoritative

First seen Oct 30, 2026 · Last verified Nov 5, 2026 (UTC)